BridgeBio Pharma, Inc.
BBIO
$76.08
$1.321.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 720.16M | 940.19M | 587.48M | 645.94M | 756.89M |
| Total Receivables | 254.48M | 205.23M | 139.44M | 116.52M | 76.87M |
| Inventory | 52.84M | 32.98M | 26.75M | 24.53M | 18.28M |
| Prepaid Expenses | 61.70M | 56.96M | 38.42M | 47.37M | 54.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.95M | 5.95M | 5.65M | 5.03M | 5.35M |
| Total Current Assets | 1.09B | 1.24B | 797.75M | 839.38M | 912.28M |
|
|
|||||
| Total Current Assets | 1.09B | 1.24B | 797.75M | 839.38M | 912.28M |
| Net Property, Plant & Equipment | 22.31M | 22.17M | 13.52M | 12.38M | 12.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 26.64M | 27.36M | 28.08M | 28.80M | 29.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.12M | 18.62M | 16.71M | 25.52M | 18.11M |
| Total Assets | 1.22B | 1.37B | 936.03M | 998.25M | 1.08B |
|
|
|||||
| Total Accounts Payable | 27.20M | 29.06M | 36.23M | 18.70M | 26.13M |
| Total Accrued Expenses | 306.63M | 229.28M | 238.36M | 183.52M | 129.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 551.27M | 551.92M | 6.19M | 5.29M | 4.78M |
| Total Finance Division Other Current Liabilities | 5.55M | 6.12M | 7.19M | 9.09M | 15.04M |
| Total Other Current Liabilities | 5.55M | 6.12M | 7.19M | 9.09M | 15.04M |
| Total Current Liabilities | 890.65M | 816.37M | 287.97M | 216.60M | 175.85M |
|
|
|||||
| Total Current Liabilities | 890.65M | 816.37M | 287.97M | 216.60M | 175.85M |
| Long-Term Debt | 2.81B | 2.80B | 1.85B | 2.69B | 1.85B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.97M | 14.22M | 3.81M | 3.43M | 4.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.66M | 12.01M | 868.35M | 13.81M | 829.17M |
| Total Liabilities | 3.72B | 3.64B | 3.01B | 2.92B | 2.86B |
|
|
|||||
| Common Stock & APIC | 2.16B | 2.11B | 2.06B | 2.02B | 1.98B |
| Retained Earnings | -4.14B | -3.99B | -3.82B | -3.63B | -3.45B |
| Treasury Stock & Other | -533.29M | -405.78M | -323.26M | -323.27M | -323.28M |
| Total Common Equity | -2.52B | -2.28B | -2.09B | -1.93B | -1.79B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.52B | -2.28B | -2.09B | -1.93B | -1.79B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.32M | 9.49M | 10.03M | 10.34M | 9.44M |
| Total Equity | -2.51B | -2.27B | -2.08B | -1.92B | -1.78B |
|
|
|||||